- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04928872
Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
The Relation Between the Meal Macronutrient Distribution and Plasma Metabolites to Model the Composition of Meals of Patients With Diabetes II and Cardiovascular Disease.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study involves 1 screening visit of approximately 1 hour and 9 study days of approximately 8 hours. Subjects will be asked to arrive in the fasted state on all study days. Fasting prior to screening is not required. On the screening day, body weight, height, and body composition by Dual-energy X-ray absorptiometry (DXA) will be measured. In addition, habitual dietary intake, physical activity level (PASE), and quality of life (SGRQ-C) will be assessed.
To test the relation between plasma amino acid, triglycerides, and glucose concentration measured by standard methods (such as finger stick) and continuous wearable devices, a premarket FDA-approved continuous glucose monitor (CGM) from Abbott (FreeStyle Libre Pro) that monitors glucose concentrations every 15 min is used. The single-use sensors are placed on the upper arm and contain a very tiny 5 mm filament (<0.4 mm diameter) that is introduced into the skin when the sensor is placed. On the first study day, the CGM will be placed to monitor glucose concentrations until the last study day. At least every 14 days, sensors will be replaced by new ones. On each study day, body weight and height will be measured and the glucose concentration data will be downloaded from the sensor onto the reader device. A catheter will be inserted in a peripheral vein of the lower arm or hand to enable blood sampling. The arm will be put in a hot box to allow collecting arterialized venous blood samples. After taking a baseline blood sample, the predefined meal will be consumed within 10 min. Small arterialized venous blood samples (5 ml) will subsequently be drawn at times: 15, 30, 45, 60, 90, 120, 180, 240, 300, 360, 420, and 480 minutes (13 blood samples, total blood approx 65 ml). Samples will be collected in predefined tubes, plasma/serum separated, aliquoted, and stored at -80 deg. Celsius for later assays and/or send to a local accredited laboratory for the concentrations of amino acids and other parameters (including fatty acids, glucose, insulin).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
College Station, Texas, United States, 77843
- Texas A&M University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Ability to walk, sit down and stand up independently
- Ability to lie in a supine or slightly elevated position for 8.5 hours
- BMI between 25 and 35 kg/m2
- Willingness and ability to comply with the protocol
Exclusion Criteria:
- Established diagnosis of malignancy
- Established diagnosis of Insulin-Dependent Diabetes Mellitus
- History of untreated metabolic diseases including hepatic or renal disorder
- Presence of acute illness or metabolically unstable chronic illness
- Recent myocardial infarction (less than 1 year)
- Any other condition according to the PI or nurse that was found during the screening visit, that would interfere with the study or safety of the patient
- Failure to give informed consent or Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Non-diabetic older adults
|
Nine predefined meals are administered in a randomized fashion, one meal per one study day, 2-3 study days per week.
Meals have a form of drinks with different compositions of protein, carbohydrates and fat in relation to the US diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prediction models of postprandial plasma amino acid patterns in relation to the macronutrient content of predefined meals as assessed by plasma concentrations of amino acids, glucose, and/or triglycerides
Time Frame: 9 study visits: one meal per one study day, 2-3 meals per week, 8-hour blood blood sample collection after a meal intake. Study completion: 4-5 weeks.
|
Participants consume 9 predefined meals in the fasted state with macronutrient composition reflecting common meals in the US diet.
One meal is consumed during one study visit with a total of 9 visits.
A baseline sample is collected followed by an intake of one meal during one study visit.
Blood samples (in the 15-and 30-minutes interval) are collected for 8 hours after a meal intake.
Collected plasma will be used for amino acid analysis.
Statistical models will be used to predict plasma amino acids from patterns of amino acids, glucose, and/or triglycerides in the consumed meals.
|
9 study visits: one meal per one study day, 2-3 meals per week, 8-hour blood blood sample collection after a meal intake. Study completion: 4-5 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discordance of glucose measurement after an intake of the predefined meal as measured by a fingerstick, continuous glucose monitor, and certified laboratory
Time Frame: 9 study visits: one meal per one study day, 2-3 meals per week, 8-hour blood blood sample collection after a meal intake. Study completion: 4-5 weeks.
|
A continuous glucose monitor is placed during the first study visit.
Participants consume 9 predefined meals in the fasted state with macronutrient composition reflecting common meals in the US diet.
One meal is consumed during one study visit.
A baseline sample is collected followed by an intake of one meal during one study visit.
Blood samples (in the 15-and 30-minutes interval) for glucose measurements are taken and plasma samples are collected.
Plasma glucose is measured by a glucose monitor and outsourced to the certified laboratory.
Information from continuous glucose monitor is collected at the end of each study day.
|
9 study visits: one meal per one study day, 2-3 meals per week, 8-hour blood blood sample collection after a meal intake. Study completion: 4-5 weeks.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nicolaas EP Deutz, MD, PhD, Texas A&M University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2017-0886
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism
-
Göteborg UniversityÖrebro University, SwedenCompletedBlood Glucose | Lipid Metabolism | Oral Glucose Tolerance Test | Carbohydrate MetabolismSweden
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Lipid MetabolismNetherlands
-
Wageningen UniversityCompletedGlucose Metabolism | Postprandial Glucose ResponsesNetherlands
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
University of JenaCompletedGlucose Metabolism | Lipid Metabolism | SatietyGermany
-
Charite University, Berlin, GermanyUnknownGlucose Metabolism | Satiety | Endocrine MetabolismGermany
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompleted
-
University of OuluCompletedGlucose MetabolismFinland
-
Finnish Institute for Health and WelfareUnknownGlucose Metabolism
Clinical Trials on Predefined meal
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandNot yet recruitingDeath | Growth | Necrotising Enterocolitis | Duct Dependent LesionsPoland
-
University Hospital, GhentBelgium Health Care Knowledge Centre; National Institute for Health and Disability...CompletedRehabilitation | Arthroplasty, Replacement, Knee | Hip ArthrosisBelgium
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationCompleted
-
University of CopenhagenCompletedBiomarkers of Food Intake in Healthy Subjects
-
Medical University of GrazCompleted
-
Ryerson UniversityCompletedObesity | OverweightCanada
-
University Hospital TuebingenWithdrawnSeizure, EpilepticGermany
-
USDA, Western Human Nutrition Research CenterTerminatedObesity | Overweight | Body WeightUnited States
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
Quadram Institute BioscienceUnilever R&D; Clinical Research and Trials Unit (Norfolk & Norwich University...Completed